We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

placeholder="Enter search term...">
Suitcase

Lassa fever in Nigeria

17 June 2025

The Nigeria Centre for Disease Control and Prevention (NCDC) continues to report Lassa fever from across Nigeria in 2025. From 1 January 2025 to 1 June 2025 there were 5 394 suspected cases (142 deaths) across all 34 States.

Eighteen States have recorded at least one laboratory-confirmed Lassa fever case. Ninety-one percent of the 747 confirmed cases were reported from Ondo, Bauchi, Edo, Taraba, and Ebonyi States. The remaining 9% percent of confirmed cases were reported from Kogi, Gombe, Plateau, Benue, Nasarawa, Kaduna, Enugu, Delta, Cross River, Borno, Ogun. FCT and Anambra States.

Lassa fever is a type of viral haemorrhagic fever (VHF) endemic in parts of West Africa. Lassa virus is transmitted via the urine or droppings from infected rodents (Mastomys rats). Transmission can also occur via body fluids of infected people.

Advice for Travellers

The risk to travellers becoming infected or developing Lassa fever is extremely low, unless living in conditions of poor sanitation and overcrowding in rural areas where these rodents are usually found.

Travellers to known Lassa fever outbreak areas must be made aware of the risk of infection and transmission routes of Lassa virus which is most commonly through:

  • ingesting or breathing in tiny particles in the air if it has been contaminated with infected rodent excretions, for example during cleaning activities such as sweeping
  • touching objects soiled with infected rat excretions, and infecting open cuts or sores
  • eating food which has been contaminated with rat excretions

Medical personnel travelling to work in an outbreak region must follow strict infection prevention control guidance.

Travellers returning from a Lassa fever outbreak area should seek rapid medical attention by contacting NHS 24 (Scotland) or NHS 111 (rest of UK) for advice prior to attending UK medical facilities if they develop fever and have:

  • returned to the UK within 21 days from a region or area with a known outbreak of Lassa fever
  • had contact with individuals infected with a VHF

For further information, see the TRAVAX Viral Haemorrhagic Fever page.